|
|
|
42
|
0603D
|
FLUOROURACIL 50MG/ML INJ (SLS
|
FLUOROURACIL
|
FLUOROURACIL
|
10ML
|
BQ
|
3.43
|
3.43
|
VIAL
|
0
|
VIAL
|
SLS
|
SAMARTH LIFE SCIENCES
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
1000
|
ANTINEOPLASTICS
|
2026-04-01
|
|
|
IV
|
0
|
ANTINEOPLASTICS
|
|
|
|
|
42
|
0603N
|
FLURACIL 50MG/ML INJ (ZYD) FLUOROURACIL
|
FLUOROURACIL
|
FLURACIL
|
10ML
|
BQ
|
6.85
|
6.85
|
VIAL
|
0
|
VIAL
|
ZYD
|
ZYDUS
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
1000
|
ANTINEOPLASTICS
|
2026-04-01
|
|
|
IV
|
0
|
ANTINEOPLASTICS
|
|
|
|
|
40
|
0611B
|
MELPHALAN 2MG TAB (TPP/AHI)
|
MELPHALAN
|
MELPHALAN
|
50'S
|
A
|
75.05
|
1.50
|
TABLET
|
63
|
TAB
|
TPP
|
THERDOSE PHARMA PRIVATE LTD
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
B
|
1000
|
ANTINEOPLASTICS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
6
|
ANTINEOPLASTICS
|
|
|
|
|
42
|
0611B
|
MELPHALAN 2MG TAB (TPP)
|
MELPHALAN
|
MELPHALAN
|
50'S
|
B
|
79.40
|
1.59
|
TAB
|
63
|
BLIS
|
TPP
|
THERDOSE PHARMA PRIVATE LTD
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
B
|
1000
|
ANTINEOPLASTICS
|
2026-04-01
|
|
|
ORAL
|
6
|
ANTINEOPLASTICS
|
|
|
|
|
41
|
0611C
|
MELPHALAN 2MG TAB (KWA)
|
MELPHALAN
|
MELPHALAN
|
50'S
|
A
|
83.18
|
1.6636
|
TAB
|
63
|
BOX
|
KWA
|
KWALITY PHARMACEUTICALS
|
ATB
|
ANSA TRADING BARBADOS LTD
|
B
|
1000
|
ANTINEOPLASTICS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
ANTINEOPLASTICS
|
|
|
|
|
40
|
0621B
|
MERCAPTOPURINE 50MG TAB (SLS/AHI)
|
MERCAPTOPURINE
|
MERCAPTOPURINE
|
30'S
|
A
|
45.64
|
1.52
|
TABLET
|
60
|
TAB
|
SLS
|
SAMARTH LIFE SCIENCES
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
B
|
1000
|
ANTINEOPLASTICS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
6
|
ANTINEOPLASTICS
|
|
|
|
|
41
|
0621B
|
MERCAPTOPURINE 50MG TAB (SLS)
|
MERCAPTOPURINE
|
MERCAPTOPURINE
|
30'S
|
A
|
45.64
|
1.5214
|
TAB
|
60
|
BOX
|
SLS
|
SAMARTH LIFE SCIENCES
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
B
|
1000
|
ANTINEOPLASTICS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
ANTINEOPLASTICS
|
|
|
|
|
42
|
0621B
|
MERCAPTOPURINE 50MG TAB (SLS)
|
MERCAPTOPURINE
|
MERCAPTOPURINE
|
30'S
|
A
|
45.64
|
1.52
|
TAB
|
60
|
BLIS
|
SLS
|
SAMARTH LIFE SCIENCES
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
B
|
1000
|
ANTINEOPLASTICS
|
2026-04-01
|
|
|
ORAL
|
6
|
ANTINEOPLASTICS
|
|
|
|
|
40
|
0621C
|
PURINETHOL 50MG TAB (ASG/STO) MERCAPTOPURINE
|
MERCAPTOPURINE
|
PURINETHOL
|
25'S
|
A
|
104.38
|
4.18
|
TABLET
|
60
|
TAB
|
ASG
|
ASPEN OSD (GLOBAL)
|
STO
|
BRYDEN STOKES LTD
|
B
|
1000
|
ANTINEOPLASTICS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
6
|
ANTINEOPLASTICS
|
|
|
|
|
41
|
0621C
|
PURINETHOL 50MG TAB (ASG) MERCAPTOP (C)
|
MERCAPTOPURINE
|
PURINETHOL
|
25'S
|
C
|
107.51
|
4.3004
|
TAB
|
60
|
BOX
|
ASG
|
ASPEN OSD (GLOBAL)
|
STO
|
BRYDEN STOKES LTD
|
B
|
1000
|
ANTINEOPLASTICS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
ANTINEOPLASTICS
|
|
|
|
|
42
|
0621C
|
PURINETHOL 50MG TAB (ASG) MERCAPTOP
|
MERCAPTOPURINE
|
PURINETHOL
|
25'S
|
C
|
114.79
|
4.59
|
TAB
|
60
|
BLIS
|
ASG
|
ASPEN OSD (GLOBAL)
|
STO
|
BRYDEN STOKES LTD
|
B
|
1000
|
ANTINEOPLASTICS
|
2026-04-01
|
|
|
ORAL
|
6
|
ANTINEOPLASTICS
|
|
|
|
|
40
|
06319
|
METHOTREXATE 2.5MG TAB (REM/SBI)
|
METHOTREXATE
|
METHOTREXATE
|
10X10
|
A
|
14.79
|
0.15
|
TABLET
|
32
|
TAB
|
REM
|
REMEDICA LTD
|
SBI
|
MASSY DISTRIBUTION (BDOS) LTD
|
B
|
1000
|
ANTINEOPLASTICS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
6
|
ANTINEOPLASTICS
|
|
|
|
|
42
|
06319
|
METHOTREXATE 2.5MG TAB (REM)
|
METHOTREXATE
|
METHOTREXATE
|
10X10
|
A
|
13.32
|
0.13
|
TAB
|
32
|
BLIS
|
REM
|
REMEDICA LTD
|
SBI
|
MASSY DISTRIBUTION (BDOS) LTD
|
B
|
1000
|
ANTINEOPLASTICS
|
2026-04-01
|
|
|
ORAL
|
6
|
ANTINEOPLASTICS
|
|
|
|
|
40
|
0631AD
|
METHOTREXATE 2.5MG TAB (INP/AHI)
|
METHOTREXATE
|
METHOTREXATE
|
100'S
|
A
|
12.72
|
0.13
|
TABLET
|
32
|
TAB
|
INP
|
INTAS PHARMACEUTICALS LTD
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
B
|
1000
|
ANTINEOPLASTICS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
6
|
ANTINEOPLASTICS
|
|
|
|
|
41
|
0631AG
|
ZUVITREX 2.5MG TAB (ZUV) METHOTREXATE
|
METHOTREXATE
|
ZUVITREX
|
100'S
|
A
|
13.32
|
0.1332
|
TAB
|
32
|
BOX
|
ZUV
|
ZUVIUS
|
PHA
|
PHARMACY SALES CARIBBEAN
|
B
|
1000
|
ANTINEOPLASTICS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
ANTINEOPLASTICS
|
|
|
|
|
41
|
0631D
|
METHOTREXATE 2.5MG TAB (REM)
|
METHOTREXATE
|
METHOTREXATE
|
100'S
|
A
|
14.79
|
0.1479
|
TAB
|
32
|
BOTT
|
REM
|
REMEDICA LTD
|
SBI
|
MASSY DISTRIBUTION (BDOS) LTD
|
B
|
1000
|
ANTINEOPLASTICS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
ANTINEOPLASTICS
|
|
|
|
|
40
|
0631Y
|
METHOTREXATE 2.5MG TAB (FSB/ATB)
|
METHOTREXATE
|
METHOTREXATE
|
100'S
|
A
|
7.48
|
0.07
|
TABLET
|
32
|
TAB
|
FSB
|
FLAGSHIP BIOTECH
|
ATB
|
ANSA TRADING BARBADOS LTD
|
B
|
1000
|
ANTINEOPLASTICS
|
2022-04-01
|
2022-09-30
|
|
Oral
|
6
|
ANTINEOPLASTICS
|
2022-03-30
|
|
|
|
42
|
0633AB
|
BIOTREXATE 25MG/ML INJ (ZYD) METHOTREXATE
|
METHOTREXATE
|
BIOTREXATE
|
2ML VIAL
|
B
|
7.58
|
7.58
|
VIAL
|
5
|
VIAL
|
ZYD
|
ZYDUS
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
1000
|
ANTINEOPLASTICS
|
2026-04-01
|
|
|
IV/IM
|
6
|
ANTINEOPLASTICS
|
|
|
|
|
42
|
0633AD
|
LEETREXATE 25MG/ML INJ (JLP) METHOTREXATE
|
METHOTREXATE
|
LEETREXATE
|
2ML VIAL
|
B
|
4.62
|
4.62
|
VIAL
|
5
|
VIAL
|
JLP
|
JOHN LEE PHARMACEUTICALS
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
1000
|
ANTINEOPLASTICS
|
2026-04-01
|
|
|
IV/IM
|
6
|
ANTINEOPLASTICS
|
|
|
|
|
40
|
0633V
|
METHACOR 25MG/ML INJ (INP/AHI) METHOTREXATE
|
METHOTREXATE
|
METHACOR
|
2ML VIAL
|
B
|
8.70
|
8.70
|
INJECTION
|
0
|
VIAL
|
INP
|
INTAS PHARMACEUTICALS LTD
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
1000
|
ANTINEOPLASTICS
|
2022-04-01
|
2024-03-31
|
|
IV
|
0
|
ANTINEOPLASTICS
|
|